Literature DB >> 8825278

Determination of acetylcholine concentration in cerebrospinal fluid of patients with neurologic diseases.

H Yamada1, M Otsuka, K Fujimoto, K Kawashima, M Yoshida.   

Abstract

INTRODUCTION: Acetylcholine (ACh) is a well known neurotransmitter in the central nervous system, but determining its level in cerebrospinal fluid (CSF) is very difficult and the origin of CSF ACh is still unknown. In this study, we attempted to measure CSF ACh by a specific and sensitive radioimmunoassay (RIA) from patients with neurologic diseases.
MATERIAL AND METHODS: Patients with cerebral infarction (n = 7), Parkinson's disease (n = 6), spinocerebellar degeneration (n = 6), Alzheimer's disease (n = 3), amyotrophic lateral sclerosis (n = 3) and disc herniation with no central nervous involvement (n = 8) participated to determine the CSF ACh levels.
RESULTS: Of these 33 patients, the mean ACh level in CSF was 282.2 +/- 61.7 fmol/ml (mean +/- SE, range 20-1505.8 fmol/ml). The mean ACh level of spinocerebellar degeneration group was lower than others, but not statistically significant.
CONCLUSION: We conclude that an amount of ACh detectable by RIA is certainly present in CSF.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8825278     DOI: 10.1111/j.1600-0404.1996.tb00175.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  6 in total

1.  Requisite role of the cholinergic alpha7 nicotinic acetylcholine receptor pathway in suppressing Gram-negative sepsis-induced acute lung inflammatory injury.

Authors:  Xiao Su; Michael A Matthay; Asrar B Malik
Journal:  J Immunol       Date:  2009-11-30       Impact factor: 5.422

Review 2.  Endogenous production of H2S in the gastrointestinal tract: still in search of a physiologic function.

Authors:  David R Linden; Michael D Levitt; Gianrico Farrugia; Joseph H Szurszewski
Journal:  Antioxid Redox Signal       Date:  2010-05-01       Impact factor: 8.401

3.  A review of butyrylcholinesterase as a therapeutic target in the treatment of Alzheimer's disease.

Authors:  Agneta Nordberg; Clive Ballard; Roger Bullock; Taher Darreh-Shori; Monique Somogyi
Journal:  Prim Care Companion CNS Disord       Date:  2013-03-07

4.  Vagal-α7nAChR signaling is required for lung anti-inflammatory responses and arginase 1 expression during an influenza infection.

Authors:  Zhao-Wei Gao; Ling Li; Yuan-Yuan Huang; Cai-Qi Zhao; Shuang-Jia Xue; Jie Chen; Zhong-Zhou Yang; Jin-Fu Xu; Xiao Su
Journal:  Acta Pharmacol Sin       Date:  2021-01-07       Impact factor: 7.169

Review 5.  Cerebrospinal fluid biochemical studies in patients with Parkinson's disease: toward a potential search for biomarkers for this disease.

Authors:  Félix J Jiménez-Jiménez; Hortensia Alonso-Navarro; Elena García-Martín; José A G Agúndez
Journal:  Front Cell Neurosci       Date:  2014-11-11       Impact factor: 5.505

6.  Relation between pro-inflammatory cytokines and acetylcholine levels in relapsing-remitting multiple sclerosis patients.

Authors:  Marcella Reale; Federica de Angelis; Marta di Nicola; Elisabetta Capello; Maria di Ioia; Giovanna de Luca; Alessandra Lugaresi; Ada Maria Tata
Journal:  Int J Mol Sci       Date:  2012-10-03       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.